Forsyth Barr highlights 'hidden gem' and growth opportunity at Ebos

Forsyth Barr highlights 'hidden gem' and growth opportunity at Ebos
Ebos has room to grow. (Image: Ebos)
Rebecca Howard
Ebos Group’s Australian Biotechnologies is a "hidden gem" while Transmedic offers a solid platform for future growth, Forsyth Barr analysts said.The two businesses represent about 15% of the group’s FY25 earnings before interest, taxes, depreciation and amortisation and “have higher organic growth than the group over the medium term”, Matt Montgomerie and Benjamin Crozier said.Both were initially acquired as part of its A$1.16 billion (NZ$1.25b)  LifeHealthcare acquisition, which was completed in May 2022....

More Markets

Retailers say unseasonable weather compounded woes
Retail

Retailers say unseasonable weather compounded woes

The Warehouse Group and KMD Brands have both downgraded guidance in recent weeks.

Fonterra’s NZ milk collections hit five-year high
Primary Sector

Fonterra’s NZ milk collections hit five-year high

The increased production comes as forecast milk prices point to record levels.

Fisher & Paykel Healthcare helps NZX up 1%
Markets Market Close

Fisher & Paykel Healthcare helps NZX up 1%

Skellerup Holdings shares rose 5.1%. 

Gregor Thompson 01 Jul 2025